Skip to content
CNS Clinical Research

San Diego, California

CNS clinical trials in San Diego, CA

53 CNS studies are recruiting participants at sites in San Diego as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Diego at a glance

  • 53 studies are recruiting at a site in San Diego.
  • By phase: Phase 1/2 (1), Phase 2 (10), Phase 2/3 (1), Phase 3 (17), Phase 4 (2), No phase (18), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (27), university, hospital or other (22), government (4).
  • By research area: Depression (23), Schizophrenia (14), Epilepsy (7), Migraine (4), ADHD (2), Parkinson's Disease (2), Bipolar Disorder (1).
  • Most recent update to one of these records: November 12, 2026.

Depression studies recruiting in San Diego

Basic details from each study's public record (the 30 most recently updated of 53). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Study site
    Kadima Neuropsychiatry Institute
    Registry record
    NCT07002034 · updated
  2. A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Definium Therapeutics US, Inc.
    Study site
    Kadima Neuropsychiatry Institute
    Registry record
    NCT07592689 · updated
  3. An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

    • No phase
    • Ages 18 and older
    • Female participants
    Sponsor
    San Diego State University
    Study sites
    San Diego State University · UC San Diego Health
    Registry record
    NCT07792837 · updated
  4. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Kaiser Permanente-San Diego Zion · UC San Diego Medical Center - Hillcrest
    Registry record
    NCT06748222 · updated
  5. A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Artemis Institute for Clinical Research
    Registry record
    NCT07716098 · updated
  6. Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06966401 · updated
  7. A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tonix Pharmaceuticals, Inc.
    Registry record
    NCT07621237 · updated
  8. ALTO-207 in Adults With Treatment-resistant Depression (TRD)

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Alto Neuroscience
    Registry record
    NCT07553637 · updated
  9. Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2)

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    San Diego State University
    Study site
    San Diego State University
    Registry record
    NCT06753123 · updated
  10. Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT07484217 · updated
  11. A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Draig Therapeutics Ltd
    Study site
    Draig Clinical Site
    Registry record
    NCT07300969 · updated
  12. A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07105111 · updated
  13. Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

    • No phase
    • Ages 18 to 85
    • All sexes
    Sponsor
    University of California, San Diego
    Study site
    UCSD Interventional Psychiatry
    Registry record
    NCT07217223 · updated
  14. Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    VA San Diego Healthcare System, San Diego, CA
    Registry record
    NCT06162741 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in San Diego, CA on ClinicalTrials.gov.

Schizophrenia studies recruiting in San Diego

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT06887192 · updated
  2. Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis

    • No phase
    • Ages 12 to 30
    • All sexes
    Sponsor
    University of California, San Diego
    Study site
    University of California, San Diego
    Registry record
    NCT07756567 · updated
  3. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT07459647 · updated
  4. NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07114874 · updated
  5. 52-week Open Label Safety-Tolerability Study

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    Synergy San Diego
    Registry record
    NCT07369154 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in San Diego, CA on ClinicalTrials.gov.

Bipolar disorder studies recruiting in San Diego

  1. An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07288320 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in San Diego, CA on ClinicalTrials.gov.

ADHD studies recruiting in San Diego

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Study site
    University of California, San Diego (Rady Children's Hospital)
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in San Diego, CA on ClinicalTrials.gov.

Parkinson's disease studies recruiting in San Diego

  1. Blood Pressure Effects on Cognition and Brain Blood Flow in PD

    • No phase
    • Ages 50 and older
    • All sexes
    Sponsor
    University of California, San Diego
    Study site
    University of California San Diego
    Registry record
    NCT05400174 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in San Diego, CA on ClinicalTrials.gov.

Epilepsy studies recruiting in San Diego

  1. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Study site
    University of California San Diego
    Registry record
    NCT05135091 · updated
  2. Diagnosing Epilepsy To EffeCT Change

    • No phase
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    UC San Diego Health
    Registry record
    NCT07110337 · updated
  3. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    • Observational
    • Ages 18 to 75
    • All sexes
    Sponsor
    Epiminder America, Inc.
    Study site
    UC San Diego Health
    Registry record
    NCT07110454 · updated
  4. A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders

    • Phase 2
    • Ages 2 to 60
    • All sexes
    Sponsor
    Scripps Translational Science Institute
    Study site
    Scripps Research Translational Institute
    Registry record
    NCT07847918 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in San Diego, CA on ClinicalTrials.gov.

Migraine studies recruiting in San Diego

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Paradigm Clinical Research Centers, LLC
    Registry record
    NCT07816367 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Acclaim Clinical Research
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Acclaim Clinical Research
    Registry record
    NCT07674654 · updated
  4. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Paradigm Clinical Research - San Diego /ID# 269608
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in San Diego, CA on ClinicalTrials.gov.

Ask about studies near San Diego

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call